Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner and ongoing support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Technology
SectorMedical
Phone212-918-1800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$635.70 million
Profitability
Miscellaneous
Employees1,680
Next Earnings Date4/18/2019 (Estimated)
OptionableOptionable
Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions
What is Medidata Solutions' stock symbol?
Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."
How were Medidata Solutions' earnings last quarter?
Medidata Solutions Inc (NASDAQ:MDSO) posted its quarterly earnings data on Tuesday, February, 12th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.08. The firm had revenue of $167.19 million for the quarter, compared to analysts' expectations of $168.08 million. Medidata Solutions had a net margin of 8.17% and a return on equity of 10.03%. The company's quarterly revenue was up 18.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.41 EPS. View Medidata Solutions' Earnings History.
When is Medidata Solutions' next earnings date?
What guidance has Medidata Solutions issued on next quarter's earnings?
Medidata Solutions updated its FY 2019 earnings guidance on Tuesday, February, 12th. The company provided earnings per share (EPS) guidance of $1.71-1.82 for the period, compared to the Thomson Reuters consensus estimate of $1.84. The company issued revenue guidance of $734-746 million, compared to the consensus revenue estimate of $749.49 million.
What price target have analysts set for MDSO?
10 Wall Street analysts have issued 1-year price targets for Medidata Solutions' stock. Their forecasts range from $70.00 to $90.00. On average, they expect Medidata Solutions' stock price to reach $83.70 in the next year. This suggests a possible upside of 8.2% from the stock's current price. View Analyst Price Targets for Medidata Solutions.
What is the consensus analysts' recommendation for Medidata Solutions?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.
Has Medidata Solutions been receiving favorable news coverage?
Media stories about MDSO stock have trended somewhat positive on Tuesday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medidata Solutions earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
Who are some of Medidata Solutions' key competitors?
Some companies that are related to Medidata Solutions include Cerner (CERN), IDEXX Laboratories (IDXX), Incyte (INCY), Smith & Nephew (SNN), AmerisourceBergen (ABC), BioMarin Pharmaceutical (BMRN), Teva Pharmaceutical Industries (TEVA), UCB (UCBJF), OLYMPUS CORP/S (OCPNY), Laboratory Corp. of America (LH), ABIOMED (ABMD), Ono Pharmaceutical (OPHLF), Cardinal Health (CAH), Universal Health Services (UHS) and Cooper Companies (COO).
What other stocks do shareholders of Medidata Solutions own?
Who are Medidata Solutions' key executives?
Medidata Solutions' management team includes the folowing people:
- Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)
- Mr. Glen M. de Vries, Co-Founder, Pres & Director (Age 47)
- Mr. Rouven Bergmann, CFO & Chief Accounting Officer (Age 46)
- Mr. Michael I. Otner, Exec. VP, Gen. Counsel & Sec. (Age 48)
- Mr. Michael Pray, Exec. VP of Sales (Age 53)
Who are Medidata Solutions' major shareholders?
Medidata Solutions' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.43%), American Century Companies Inc. (2.56%), Bank of New York Mellon Corp (2.41%), Canada Pension Plan Investment Board (1.81%), Royce & Associates LP (1.79%) and Nikko Asset Management Americas Inc. (1.76%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.
Which institutional investors are selling Medidata Solutions stock?
MDSO stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Polen Capital Management LLC, Eagle Asset Management Inc., Global Thematic Partners LLC, Brown Advisory Inc., New York State Common Retirement Fund, Frontier Capital Management Co. LLC and First Quadrant L P CA. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael Pray, Robert Taylor and Rouven Bergmann. View Insider Buying and Selling for Medidata Solutions.
Which institutional investors are buying Medidata Solutions stock?
MDSO stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Nikko Asset Management Americas Inc., BlackRock Inc., Polar Capital LLP, Royce & Associates LP, Dimensional Fund Advisors LP, Dimensional Fund Advisors LP and Rhumbline Advisers. View Insider Buying and Selling for Medidata Solutions.
How do I buy shares of Medidata Solutions?
Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medidata Solutions' stock price today?
One share of MDSO stock can currently be purchased for approximately $77.38.
How big of a company is Medidata Solutions?
Medidata Solutions has a market capitalization of $4.82 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,680 workers across the globe.
What is Medidata Solutions' official website?
How can I contact Medidata Solutions?
Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]
MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
